Yvonne Mowery

Targeting TRPV1-Containing Nerves for Radiation-Induced Pain and Oral Mucositis

National Institute of Dental and Craniofacial Research · R21

PI · $437.3K · University of Pittsburgh at Pittsburgh

Employing Novel Primary Mouse Models of Head and Neck Cancer to Overcome Chemoradiation Resistance

National Institute of Dental and Craniofacial Research · K08

Contact PI · $804.1K · University of Pittsburgh at Pittsburgh

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

Principal investigator · Recruiting · Phase 1

National Cancer Institute (NCI)

Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer

Principal investigator · Recruiting

Yvonne Mowery

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

Principal investigator · Active not recruiting · Phase 1

National Cancer Institute (NCI)

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Site PI · Recruiting · Phase 2

NRG Oncology